DRUGS	sens assoc	res assoc	tot
1011 - ABT-263 [BCL2, BCL2L1, BCL2L2]	2	0	2
119 - Lapatinib [ERBB2, EGFR]	2	0	2
1268 - XAV 939 [TNKS1 (tankyrase-1)]	0	2	2
167 - OSU-03012 [PDPK1 (PDK1)]	1	1	2
204 - Tipifarnib [Farnesyl-transferase (FNTA)]	0	2	2
255 - CP724714 [ERBB2]	2	0	2
1003 - Camptothecin [TOP1]	0	1	1
1010 - Gefitinib [EGFR]	1	0	1
1020 - Lenalidomide [TNFA]	0	1	1
1030 - KU-55933 [ATM]	1	0	1
1032 - Afatinib [ERBB2, EGFR]	1	0	1
1057 - NVP-BEZ235 [PI3K (Class 1) and MTORC1/2]	0	1	1
1114 - Cetuximab [EGFR]	1	0	1
1218 - JQ1 [BRD2, BRD3, BRD4]	1	0	1
1375 - Temozolomide [DNA akylating agent]	0	1	1
1377 - Afatinib (rescreen) [ERBB2, EGFR]	1	0	1
140 - Vinorelbine [Microtubules]	0	1	1
147 - NSC-87877 [PTPN6 (SHP-1), PTPN11 (SHP-2)]	1	0	1
150 - Bicalutamide [ANDR (androgen receptor)]	1	0	1
1526 - RDEA119 (rescreen) [MAP2K1 (MEK1), MAP2K2 (MEK2)]	0	1	1
159 - HG-6-64-1 [BRAFV600E, TAK, MAP4K5]	0	1	1
170 - Shikonin [unknown]	1	0	1
180 - Thapsigargin [sarco-endoplasmic reticulum Ca2+-ATPases]	0	1	1
184 - BMS-754807 [IGF1R]	0	1	1
201 - Epothilone B [Microtubules]	0	1	1
206 - Ruxolitinib [JAK1, JAK2, TYK2]	1	0	1
224 - AS605240 [PI3Kgamma]	1	0	1
235 - QL-XII-47 [BTK, BMX]	0	1	1
275 - I-BET [BRD2, BRD3, BRD4]	1	0	1
293 - MP470 [PDGFR]	1	0	1
301 - PHA-793887 [CDK-pan]	1	0	1
306 - TG101348 [JAK2]	1	0	1
312 - AV-951 [VEGFR]	1	0	1
41 - S-Trityl-L-cysteine [KIF11]	0	1	1
53 - CGP-60474 [CDK1,CDK2,CDK5,CDK7,CDK9]	0	1	1
88 - MS-275 [HDAC]	0	1	1